These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26074866)

  • 1. Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.
    Di Battista AP; Buonora JE; Rhind SG; Hutchison MG; Baker AJ; Rizoli SB; Diaz-Arrastia R; Mueller GP
    Front Neurol; 2015; 6():110. PubMed ID: 26074866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple indicators model of long-term mortality in traumatic brain injury.
    Gradisek P; Osredkar J; Korsic M; Kremzar B
    Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
    Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
    EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit.
    Kedziora J; Burzynska M; Gozdzik W; Kübler A; Kobylinska K; Adamik B
    Neurocrit Care; 2021 Jun; 34(3):856-866. PubMed ID: 32978732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
    Park DW; Park SH; Hwang SK
    Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
    Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
    J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
    Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
    J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
    Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
    Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Intensity Interval Training Is Associated With Alterations in Blood Biomarkers Related to Brain Injury.
    Di Battista AP; Moes KA; Shiu MY; Hutchison MG; Churchill N; Thomas SG; Rhind SG
    Front Physiol; 2018; 9():1367. PubMed ID: 30323770
    [No Abstract]   [Full Text] [Related]  

  • 17. Multivariate analysis of traumatic brain injury: development of an assessment score.
    Buonora JE; Yarnell AM; Lazarus RC; Mousseau M; Latour LL; Rizoli SB; Baker AJ; Rhind SG; Diaz-Arrastia R; Mueller GP
    Front Neurol; 2015; 6():68. PubMed ID: 25870583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outlier Analysis for Acute Blood Biomarkers of Moderate and Severe Traumatic Brain Injury.
    Korhonen O; Mononen M; Mohammadian M; Tenovuo O; Blennow K; Hossain I; Hutchinson P; Maanpää HR; Menon DK; Newcombe VF; Sanchez JC; Takala RSK; Tallus J; van Gils M; Zetterberg H; Posti JP
    J Neurotrauma; 2024 Jan; 41(1-2):91-105. PubMed ID: 37725575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.
    Lei J; Gao G; Feng J; Jin Y; Wang C; Mao Q; Jiang J
    Crit Care; 2015 Oct; 19():362. PubMed ID: 26455520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biomarkers in children with traumatic brain injury].
    Pinelis VG; Sorokina EG; Semenova JB; Karaseva OV; Mescheryakov SV; Chernisheva TA; Arsenieva EN; Roshal LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):66-72. PubMed ID: 26356618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.